Antidote.me is based in London, United Kingdom. It has raised $60M in total funding. Latest round: Seed.
Antidote.me funding overview
Antidote.me is based in London, United Kingdom. Antidote.me has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in January 2026. The round record for Antidote.me runs through 2026; nothing later has been disclosed. Investors on record include LBO France, Merck Global Health Innovation Fund, Smedvig Capital, Octopus Ventures. 4 distinct backers are named across the disclosed rounds.
Antidote.me at a glance
Total raised
$60M
Latest round
Seed
Latest round date
January 2026
Headquarters
London, United Kingdom
Notable investors
LBO France, Merck Global Health Innovation Fund, Smedvig Capital, Octopus Ventures
Frequently asked about Antidote.me funding
How much has Antidote.me raised?
Antidote.me has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Antidote.me?
LBO France, Merck Global Health Innovation Fund, Smedvig Capital, Octopus Ventures are named among the investors backing Antidote.me.
What was the latest Antidote.me funding round?
The most recent disclosed round is a Seed, announced in January 2026.
Where is Antidote.me based?
Antidote.me is based in London, United Kingdom.
When did Antidote.me last raise?
The last disclosed Antidote.me round closed in January 2026 at Seed.
Totals shown for Antidote.me aggregate every disclosed round on file. To see how that compares, browse the companies in London and the investors behind them below.
